Navigation Links
Market Outlook: The Future of Biomedical Materials
Date:1/21/2013

SHANGHAI, Jan. 22, 2013 /PRNewswire/ -- The "hot cake" of the China medical devices market has attracted close eyes from EU/US companies. With a perfect blend of local and international market intelligence, Dr. Daozhi Liu from MicroPort will share details about the future of biomedical materials in the Chinese market this March at BioMed China 2013.

(Photo: http://photos.prnewswire.com/prnh/20130122/CN44853 )

China's Twelfth "Five-Year Plan" has announced that, until 2015, biomedical materials such as bio-ceramics and medical metals will increase significantly in China. Regarding biomedical materials projects, the Plan clearly points out that the State will vigorously develop medical metals and alloys such as medical polymer materials, bio-ceramics, and other related products to meet the demand for artificial organs, vascular stents and implants. This will promote the field of materials technologies, life sciences and clinical trials, as well as reduce R&D risks and production costs.

Dr. Daozhi Liu is currently Senior Vice President of Emerging Business at Shanghai MicroPort Medical (Group) Limited. He obtained his bachelor's and Ph.D. in China in 1985 and 1991, as well as engaged in postdoctoral research at the University of Oxford from 1993 to 1994. He returned from overseas to join MicroPort Medical (Shanghai) Co., Ltd. as one of the core members of the early entrepreneurial team, former research center director, vice president, senior vice president, business general manager, Ortho business company legal representative and executive director. From 2003 until now, he established MicroPort's emerging business of cardiac electrophysiological medical equipment: pacemakers and orthopedic medical devices. He is also the founder and GM of Shanghai MicroPort Orthopedics Co., Ltd., a sub-branch of MicroPort in Shanghai.

Apart from presenting at BioMed China 2013 on March 14 in Shanghai, Dr. Daozhi Liu will also serve as the chairman for the full day conference and panel discussions, as well as share both his local and global key insights on biomedical materials, investment opportunities, and product value evaluation.

For more details about BioMed China 2013 and Dr. Liu's speech, please visit the event website at http://www.biomed-innovation.com/en/Index.asp. Free PowerPoint Presentations from past events can be downloaded at http://www.biomed-innovation.com/en/feedbacka.asp?Id=97.

BioMed is hosted by UBM Conferences.


'/>"/>
SOURCE UBM China
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Lucintel’s Analysis of Global Base Metal Mining Industry: Market to Reach $305 Billion in 2017
2. Lucintel’s Report Outlines Double-Digit Growth for Carbon Fiber Industry: Market to Reach $3 Billion in 2018
3. MetaStat to Present at Noble Financial Capital Markets Ninth Annual Equity Conference on January 22, 2013
4. Independent Marketing Automation Software Expert gives Positive review on MindMatrix's platform, AMP
5. Global Metabolomics Market Reviewed & Forecast in New In-Demand Report Available at MarketPublishers.com
6. Global Soil Treatment Market Forecast to Grow at a CAGR of 8.5% to 2017 in New Research Report at ReportsnReports.com
7. Agency Take-up Soars of Agnitios Leading Pull Marketing Platform for the Healthcare Industry
8. Global Healthcare Contract Research Outsourcing Market is expected to reach USD 65.03 billion by 2018: Transparency Market Research
9. CIS MDI (Methyl Diphenyl Diisocyanate) Market - New Industry Research Report Published by Transparency Market Research
10. Butanes Market - New Industry Research Report Published by Transparency Market Research
11. BioInformatics LLC New Market Report – Opportunities for New Players in the Growing Stem Cell Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ON (PRWEB) , ... June 23, 2016 , ... STACS ... DNA Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as ... the STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... Andrew D Zelenetz ... Published recently in Oncology ... touchONCOLOGY, Andrew D Zelenetz , discusses the ... is placing an increasing burden on healthcare systems ... With the patents on many biologics expiring, interest ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the ... Convention Center and will showcase its product’s latest features from June 26 to ... a scientific poster on Disrupting Clinical Trials in The Cloud during the conference. ...
Breaking Biology Technology:
(Date:6/1/2016)... , June 1, 2016 ... in Election Administration and Criminal Identification to Boost Global ... a recently released TechSci Research report, " Global Biometrics ... Region, Competition Forecast and Opportunities, 2011 - 2021", the ... billion by 2021, on account of growing security concerns ...
(Date:5/16/2016)... YORK , May 16, 2016   EyeLock ... solutions, today announced the opening of an IoT Center ... to strengthen and expand the development of embedded iris ... an unprecedented level of convenience and security with unmatched ... authenticate one,s identity aside from DNA. EyeLock,s platform uses ...
(Date:5/3/2016)... Lithuania , May 3, 2016  Neurotechnology, ... released the MegaMatcher Automated Biometric Identification System ... of large-scale multi-biometric projects. MegaMatcher ABIS can process ... accuracy using any combination of fingerprint, face or ... MegaMatcher SDK and MegaMatcher Accelerator ...
Breaking Biology News(10 mins):